Agilon Health AGL Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss at other companies
Other financials
Where this comes from
Reported directly by Agilon Health in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss.
The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agilon Health's debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agilon Health's debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss?
- Agilon Health (AGL) reported debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss of $0 in Q4 2025.
- How has Agilon Health's debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss changed year-over-year?
- Agilon Health's debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss decreased by 100.0% year-over-year, from $313K to $0.
- What is the long-term trend for Agilon Health's debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss?
- Over 2 years (2023 to 2025), Agilon Health's debt securities, available-for-sale, continuous unrealized loss position, 12 months or longer, accumulated loss has grown at a -100.0% compound annual growth rate (CAGR), from $2.34M to $0.